Featured Research

from universities, journals, and other organizations

Valve Implantation On The Beating Heart

Date:
April 21, 2009
Source:
Deutsches Aerzteblatt International
Summary:
Transcatheter valve implantation is a newly developed technique for the curative treatment of high-grade aortic stenosis. It is likely to be of benefit especially to elderly, multi-morbid patients for whom the risk of open heart surgery would be too great.

Transcatheter valve implantation is a newly developed technique for the curative treatment of high-grade aortic stenosis. It is likely to be of benefit especially to elderly, multimorbid patients for whom the risk of open heart surgery would be too great.

The initial results obtained with this technique at the German Heart Center in Munich are presented in the current issue of Deutsches Ärzteblatt International by Sabine Bleiziffer and her colleagues.

From June 2007 to September 2008, aortic valvular prostheses were successfully implanted with the transcatheter technique in 150 patients with high-grade aortic stenosis. The 30-day mortality was 11.8%, which can be compared to a figure of 24% for conventional aortic valve replacement surgery. The most common post-procedural complications were cardiac arrhythmia, vascular problems, and cerebrovascular events. Six months after the procedure, the patients' clinical condition had markedly improved, and the authors were able to demonstrate good hemodynamic functioning of the new prostheses.

Calcific aortic stenosis is the most common acquired heart valve defect in Western countries, with a prevalence of more than 3% in persons over age 75. Up to the present time, the treatment of choice for high-grade aortic stenosis has been surgical aortic valve replacement. As many as 60% of patients, however, cannot be operated on because of advanced age and major comorbidities, even though they suffer from severe symptoms and have a poor prognosis under conservative treatment.

The advantage of transcatheter valve implantation is that it can be performed on the beating heart without the need for a heart-lung machine. In the procedure, an aortic valve prosthesis crimped to fit inside the catheter is brought into aortic position and then unfolded. The catheter can be inserted transarterially, usually by way of a femoral artery puncture, or transapically, i.e., through the left ventricular apex. The technical feasibility of the procedure has already been demonstrated at multiple centers around the world.


Story Source:

The above story is based on materials provided by Deutsches Aerzteblatt International. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sabine Bleiziffer, Hendrik Ruge, Domenico Mazzitelli, Christian Schreiber, Andrea Hutter, Markus Krane, Robert Bauernschmitt, Rüdiger Lange. Valve Implantation on the Beating Heart. Deutsches Ärzteblatt International, 2009; 106(14):235%u201341

Cite This Page:

Deutsches Aerzteblatt International. "Valve Implantation On The Beating Heart." ScienceDaily. ScienceDaily, 21 April 2009. <www.sciencedaily.com/releases/2009/04/090420121337.htm>.
Deutsches Aerzteblatt International. (2009, April 21). Valve Implantation On The Beating Heart. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/04/090420121337.htm
Deutsches Aerzteblatt International. "Valve Implantation On The Beating Heart." ScienceDaily. www.sciencedaily.com/releases/2009/04/090420121337.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins